Euretos AI platform
The Euretos AI Platform is a one-of-a-kind suite of applications for target & disease research used by leading pharma and biotech companies and academic institutions.
AI integrated knowledge base
Access the largest AI integrated biomolecular knowledge base linking multi-omics data to literature, patents, experimental and clinical evidence. Assess key aspects such as multi-omics interactions, gene expression in tissues, cell types and tumors, pathway interactions, regulatory and signalling responses, gene variants, clinical trials, target tractability and patents.
Search - Optimised for disease and drug biology
- Target Assessment
- Gene-Disease Analysis
- Set Creation.
Analytics - Systems biological multi-omics insights
Gene Set Enrichment
Gene Set Ranking
Transcription Network Analysis
Knowledge Graph - Biomolecular interaction analysis
Workflows - Target discovery & assessment (and more)
Target Assessment
Gene-Disease Analysis
Target Discovery in Oncology
Target Discovery for Bispecific Antibodies.
"In this project we evaluated you against our internal investigations and the results of one other external provider. What really sets you apart is how you combine a fundamentally biological and data driven approach. The breadth of the indications you assess and the depth of your analysis sets you apart and is a clear value add to our internal capabilities."
"We have been working with Euretos for many years now. They provide us with unique tools that we use as an integral part of our target discovery and validation. Using the Euretos AI Platform is a mandatory input to our target evaluation meetings"
"We are fascinated by the suggested hypothesis. It was great that even very small expressional changes were captured and a hypothesis was generated. The interpretation was also convincing and consistent. Also the team is well engaged, and had a very good understanding in the background of the project and our research question"
Keep up with our latest news and events. Sign up for our newsletter.